ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
EKF Diagnostics Holdings Plc

EKF Diagnostics Holdings Plc (EKF)

26,00
-1,00
(-3,70%)
Geschlossen 02 Juli 5:30PM

EKF Diagnostics Holdings Plc (EKF) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
26,00
( -3,70% )
Gebot
26,00
Fragen
26,30
Volumen
592.728
25,30 Tagesbereich 26,00
21,80 52-Wochen-Bereich 31,90
Marktkapitalisierung
Handelsende
27,00
Handelsbeginn
25,90
Letzte Trade
17
@
26
(UT)
Letzter Handelszeitpunkt
Finanzvolumen
152.823p
VWAP
25,783
Durchschnittliches Volumen (3 Mio.)
307.139p
Ausgegebene Aktien
430.503.112
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
57,46
Gewinn pro Aktie (EPS)
-
Erlöse (LTM)
51,56M
Nettogewinn (LTM)
2,12M

Über EKF Diagnostics Holdings Plc

EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin an... EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. It also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab HbA1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test HbA1c, fully automated hemoglobin A1c analyzer for the monitoring and management of diabetes; and STAT-Site W Beta-Hydroxybutyrate analyzer. In addition, the company offers Creamatocrit Plus, a breast milk analyzer; QuPID and True20 pregnancy tests; Lactate Scout Vet, a handheld lactate analyzer for veterinary care; Hemo Vet, a point-of-care hemoglobin and hematocrit analyzer; Lactate Scout Sport, a lactate analyzer for sports performance; Biosen series for sports; and EKF Link, a data management solution that integrates point-of-care analyzers. Further, it offers Beta-Hydroxybutyrate LiquiColor for monitoring ketosis; RaPET, a range of immunoassay kits; QuStick Strep A for Strep A infection treatment; Hema-Screen Lab Pack for detection of colorectal cancer; PrimeStore MTM, a molecular transport medium that preserves and stabilizes DNA and RNA; Uri-Trak 120M urine analyzer; and clinical chemistry reagents, controls, and standards. Additionally, the company provides precision fermentation, custom bioprocessing, and contract manufacturing solutions; and diagnostic enzymes that include arylacylamidase, beta-hydroxybutyrate dehydrogenase, and salicylate hydroxylase. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom. Mehr anzeigen

Sektor
Healthcare
Branche
Medical Equipment & Supplies
Hauptsitz
Cardiff, United Kingdom
Gegründet
1990
EKF Diagnostics Holdings Plc is listed in the Healthcare sector of the Londoner Börse with ticker EKF. The last closing price for EKF Diagnostics was 27,00p. Over the last year, EKF Diagnostics shares have traded in a share price range of 21,80p to 31,90p.

EKF Diagnostics currently has 430.503.112 shares in issue. The market capitalisation of EKF Diagnostics is £111,93 million. EKF Diagnostics has a price to earnings ratio (PE ratio) of 57.46.

EKF Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.20.7751937984525.82725.112892626.69642354DE
4-0.9-3.3457249070626.92724.223258426.06757513DE
1214252823.431938724.99060386DE
26002628.42332710625.22105491DE
52-0.9-3.3457249070626.931.921.837790826.69950086DE
156-5.3-16.932907348231.333.718.440926426.94804444DE
260-49-65.33333333337586.818.450856436.47506565DE

EKF - Frequently Asked Questions (FAQ)

What is the current EKF Diagnostics Holdings Plc share price?
The current share price of EKF Diagnostics Holdings Plc is 26,00p
How many EKF Diagnostics Holdings Plc shares are in issue?
EKF Diagnostics Holdings Plc has 430.503.112 shares in issue
What is the market cap of EKF Diagnostics Holdings Plc?
The market capitalisation of EKF Diagnostics Holdings Plc is GBP 111,93M
What is the 1 year trading range for EKF Diagnostics Holdings Plc share price?
EKF Diagnostics Holdings Plc has traded in the range of 21,80p to 31,90p during the past year
What is the PE ratio of EKF Diagnostics Holdings Plc?
The price to earnings ratio of EKF Diagnostics Holdings Plc is 57,46
What is the cash to sales ratio of EKF Diagnostics Holdings Plc?
The cash to sales ratio of EKF Diagnostics Holdings Plc is 2,25
What is the registered address of EKF Diagnostics Holdings Plc?
The registered address for EKF Diagnostics Holdings Plc is Avon House, Cardiff, South Glamorgan, CF64 2EZ
What is the EKF Diagnostics Holdings Plc website address?
The website address for EKF Diagnostics Holdings Plc is www.ekfdiagnostics.com
Which industry sector does EKF Diagnostics Holdings Plc operate in?
EKF Diagnostics Holdings Plc operates in the Medical Equipment & Supplies sector

EKF Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen